NeurMedix Obtains FDA Authorization for Pivotal Phase 3 Alzheimer’s Trial
February 02, 2021 08:30 ET
|
NeurMedix, Inc.
SAN DIEGO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- NeurMedix, LLC, a San Diego based privately held clinical stage pharmaceutical company announced that it has received authorization from the U.S. Food...